Chilean scientist was recognized as one of the best researchers in Australia

01-28-2021

Murgas

Dr. Eduardo Albornoz, who is an associate researcher at the U. Mayor Center for Integrative Biology, is doing a post-doctorate at the University of Queensland, where he is working on possible therapeutic targets to treat neurodegenerative diseases such as Parkinson's and amyotrophic lateral sclerosis. Thus, a few days ago he was named among the four "best emerging health researchers" of 2020 in that country.

Eduardo Albornoz does not like the treatment of "Dr." nor is it that struggle of "egos" which he has had to face many times in his career as a scientist. However, at 36 years old and with a career focused on stopping the development of neurodegenerative diseases, it is a title more than earned, to the point that today he is one of the best researchers in Australia, the country where he has resided since he did his doctorate in 2014.

A week ago, the Chilean received the "Bupa Health Foundation 2020 Emerging Health Researcher Award", awarded only to the "brightest" scientists who stand out for their careers and the tangible impact their work has on health of the community.

“Science is not easy, it is a lot of love for art. In this type of work you have to deal with many episodes of frustration. I would say that 90% of the things that you do in the laboratory do not work, but you have to persevere and continue. This award, without a doubt, is a motivation to continue and you realize that you are on the right path ”, says Eduardo

In love with science

The researcher, a native of Lonquén, Talagante commune, began his career when he entered the University Andrés Bello to study Biochemistry. And although it was his second option after Medicine, he was enchanted with it and decided not to change

I fell in love with research and science along the way. To be honest, being a scientist was not promoted much at school, so it was something I discovered over time, "he says.

University of Queensland: His New Home
After several months of analysis on where to go, in 2014 the scientist received the scholarship for outstanding international students at the University of Queensland, Australia, to do a doctorate at the Institute of Molecular Biosciences (IMB).

In this context, he affirms that "he was lucky". This, because just before applying, the laboratory in which he did his doctorate, validated and published in the journal "Nature Medicine" a new drug, MCC950, which acts on the innate immune system, by inhibiting the inflammasome, becoming in an excellent candidate to stop inflammatory processes in the brain. That is why they also paid attention to his CV and this ended up becoming his doctoral project.

"I was offered to test this new drug in Parkinson's models and the results were impressive. We not only validated this new therapeutic target in humans, but we were able to stop the progression of neurodegeneration (cell death) in preclinical models. This validates NLRP3 as a pharmacological therapeutic target for Parkinson's disease ”, explains the Chilean.

In addition, he says that he identified a possible biomarker that could revolutionize the field of neurodegenerative diseases. This type of discoveries has allowed it to be awarded different Australian and international funds to continue its investigations, including one from the Michael J Fox Foundation.

After finishing his Ph.D. in 2019, he continued his post-doctoral studies, in the neuroinflammation laboratory of the School of Biomedical Sciences of the same university, focusing on testing new drugs in preclinical models and understanding the role of peripheral innate immunity in neurodegenerative diseases, including motor neuron disease (Amyotrophic Lateral Sclerosis), Huntington and Parkinson's disease.

In addition, in the context of the pandemic, he is investigating the role of viral infections such as SARS-Cov2 in activating inflammatory processes in the brain, which could trigger neurodegenerative diseases such as Parkinson's.

“My dream has always been that my work in the laboratory has a global impact and in some way be a contribution to knowledge and medicine. It is satisfying that the effort of so many years is beginning to bear fruit. I believe that if the clinical trials are successful, we could change the history of neurodegenerative diseases and help many people who suffer from these disabling diseases, so that they have a better quality of life ”, he says.

How did he arrive to U. Mayor

Dr. Paola Murgas from CIB U. Mayor (who appears in the photo) contacted Eduardo after reading an article about his work in Heureka magazine. This is how they met and when the researcher traveled to Australia they created ties between the two universities. This included the signing of an agreement that allows them to work and publish together, in addition to making exchanges

“This experience has been great. I always had that bitter feeling of not being able to contribute to my country being so far away. But thanks to this link with the U. Mayor, I found a way to give back to Chile from a distance ”, says Albornoz.

And although the scientist acknowledges that it has not been easy to be away from his family, and that he regrets having missed the birth of his first niece, he does not plan to return to Chile.
Today, with an Australian residence, he has already begun to build a life with his Brazilian partner from the other side of the world, from where he will continue his investigative work to change the course of this type of disease.

Source: https://www.diariomayor.cl/cie...


Recent News

Interview to Felipe Court in Duna Radio

Chileans are searching for the origin of autism in a brain protein

CIB and Center for Nanotechnology work together to develop a joint research

GERO and U3E analized how aging is developed in Chile

Students from CIB won first place in Science Fair

Investigator warns :"Stem cells are not magic"

Patricio Manque and the Human Genome Revolution in Protagonistas 2030

Second Contest: Centers for Research on Aging Stay

Through lectures about the challenges of future, U.Mayor took part in "Protagonistas 2030"

Research Centers from U.Mayor open their doors to undergraduates to show how they work

Vice Chancellor explained the unknown role of bacteria in Alzheimer or food alergies.

Felipe court, Ph.D. took part in the international congress organized by Spinal Research Foundation in UK.

CIB Investigator conducting a research internship at Institut Curie, Paris, France

Paola Murgas Ph.D. talks about Nobel Prize given to immunologists

Dr. Mario Sanhueza from the Center for Integrative Biology at Universidad Mayor obtains a project for insertion in the Academia.

CIB investigator Carol San Martín talked about World Alzheimer´s Day

Scientists from the Center for Integrative Biology at Universidad Mayor obtains two Conicyt projects for the formation of International Networks 2018.

Center for Integrative Biology is awarded 2 projects "Fondecyt de Iniciación 2018", from the 13 awarded to Universidad Mayor.

Can Aging be controlled? Check how our Center for Integrative Biology Works

Scientists will use Drosophila for decoding Parkinson's symptoms

U. Mayor granted with 8 Fondecyt Projects for a total sum of CLP$1600m

The effect of autophagy on brain health

With cutting-edge technology: Chilean study seeks to create the rejuvenating brain injection to fight Parkinson's

Center of Integrative Biology at Universidad Mayor seeks a Veterinary Technician

Biome Therapeutics is looking for Lead Scientist

Geroscience Center for Brain Health and Metabolism seeks motivated post-doctoral researchers

Center of Integrative Biology began seminar cycle with talks about cancer cell treatment

PHD in neurobiology began its version 2019 with talks by Outstanding Scientists

What Do We know about diseases that affect the brain? Scientific research as a motor of change in society

The prevention of Parkinson's would be in the intestine

Director of the CIB awarded project of the Michael J. Fox Foundation to study new therapeutic targets against Parkinson's

Universidad Mayor Researcher detailed the main behaviors that would boost the onset of brain diseases

Michael J. Fox Foundation supports Chilean laboratory to develop therapy against Parkinson's.

Researcher published article in prestigious journal Nature Communications together with academics from Belgium

Researchers from the Center for Integrative Biology (CIB) of the Universidad Mayor Participate in a publication in the high impact journal Nature Cell Biology.

U. Mayor and Huawei agree joint collaboration on technology and research

Center for Integrative Biology presented advances in its research on Alzheimer's and ELA

Artist and Scientist transform photographs of neural networks into works of art

U. Mayor Scientists integrate team that delivered a national proposal to prevent dementias

Scientist U. Mayor organized symposium on glial cells in Portugal

Test gene therapy in Huntington's disease

2020 Accreditation and increase of indicators: Review the keys of the Third Meeting of Researchers U. Mayor

New finding adds evidence on the role of the microbiota in health: The state of the bacterial flora influences cancer survival

Researchers from Uruguay and Mexico carry out an internship at the Center for Integrative Biology to study cell aging.

Universidad Mayor will sponsor the World Congress on Aging that will host Chile.

U. Mayor is awarded $ 240 million and becomes the only private institution among the winners of the Fondequip.

Director of the CIB U. Mayor participates in research that created a method that successfully slows the progress of Parkinson's

CIB academics presented their research at congress on mitochondria and cancer in Prague

Medical technologists reward thesis work done by students of the U. Mayor

European Cancer Research Association selects the work of our researcher Erick Riquelme as one of the 10 most important works

U. Mayor CIB researcher traveled to the laboratory of Dr. Koichi Kawakami, one of the drivers of transgenesis in zebrafish

150 Years of Nature and Chilean scientists who have managed to publish in the famous magazine.

Erick Riquelme, medical technologist: Scientist works to create the first Chilean cancer research network

Researcher U. Mayor describes gene associated with autism and regulating the formation of the cerebral cortex

Largest study of its kind in which 50 centers participated: Finding 102 genes associated with autism opens doors to better diagnosis and more therapies.

CIB Coordinator participated in the organization of the first meeting of Microscopy Units of Chilean universities

VIP Projects: the tool that fosters the link between undergraduate and research carried out in the U. Mayor.

Felipe Court: "The lower the level of education, the greater the probability of having Alzheimer's"

U. Mayor researcher study suggests ketogenic diet may help treat a group of muscle diseases known as dysferlinopathies.

"Coronavirus: How to face the pandemic?"

About 100 undergraduate students have completed internships at the U. Mayor Research Centers

U. Mayor signs research agreements with three top 70 universities in international rankings

Director of the CIB details the progress of his research on the reduction of neuropathies caused by chemotherapies

U. Mayor researchers discover cellular mechanism that would be key to increase neuronal regeneration

INVESTIGATION // U. Mayor scientists discover possible therapy that would decrease neurodegeneration in Huntington's disease

U. Mayor scientists discover key mechanism in neuronal regeneration

Vaccine developed by the U. of Oxford opens the hope of a cure for the virus / Participation of Dra. Paola Murgas about the topic

Three thousand Chilean volunteers and six hospitals would test the virus vaccine / Participation of Dra. Paola Murgas about the topic

Chilean scientists create and patent new and innovative therapy for deadly neurodegenerative disease

CIB researchers lead a team that discovered a possible therapeutic target to fight various types of cancer

U. Mayor researchers are part of a team that will seek to generate an early diagnosis to detect Alzheimer's.

Covid // U. Mayor implements rapid testing system for covid-19 to restart Investigation efforts

How is the race for the covid-19 vaccine progressing?

The Gero Center of the U. Mayor renews a project that has studied aging in Chile for 5 years.

Parkinson's disease, dementia and the nervous system: This is how the GERO U. Mayor Center works

Talks // Center for Integrative Biology takes up talks on popular science for children in Huechuraba

Scientists highlight a CIB researcher, who spoke at the main event on Neuroscience in Chile

Director of the Center for Integrative Biology of the U. Mayor is a member of the Latin American network for research on dementia

Mayor U. rises 29 places in the 2020 Research Quality ranking of La Tercera and is ranked 9

CIB member investigates key treatment for a group of muscle diseases

CIB academic led the first study on the importance of Vitamin D at the cellular level in Chile

Dr. Gonzalo Ignacio Cancino, participated in the IBRO Alumni Zoom Party 2021

Dr. Gonzalo Ignacio Cancino was invited to give a talk at the Department of Medical Genetics of the University of Alberta, Canada

Researchers from the CIB U. Mayor discover neural benefits in the consumption of murtilla

Outstanding panelists discussed the importance of quality aging in Chile

3 Researchers from our center are awarded REGULAR AND POSTDOCTORAL FONDECYT.

Researcher U. Mayor discovers a possible new therapeutic target for leukemia

Chilean scientist was recognized as one of the best researchers in Australia

The coronavac vaccine and its application to older adults, according to the opinion of Dr. Paola Murgas

Technology "made in Chile": the contributions of national scientists to face the pandemic

CIB researcher was noted for her dissemination of science among children

Vaccination vs. contagions: how to evaluate the Chilean process?

Felipe Court Goldsmith's Recommended

Gero Center premiered the third version of "GeroTalks" with a talk about inequality in Alzheimer's

US approves first new Alzheimer's drug in nearly 20 years

Researcher U. Mayor analyzed advances in the study on Alzheimer's and aging

Academics and students launch magazine with interviews with outstanding Chilean scientists